In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long-term treatment using a small molecule drug that reduces activity of the brain’s stress circuitry significantly reduces Alzheimer’s disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative condition.
from Dementia Big http://ift.tt/1WWA1cE via advanced dementia
http://ift.tt/1HQZXjc
No comments:
Post a Comment